Skip to content
Private label

Needle-free peptides.Your brand. Our gels.

Leading supplier of high quality gel-based peptides to US telehealth companies

Made in a 503A and an FDA-registered 503B facility.

What is Geltides?

Who we supply

We make needle-free peptide gels and supply them to US telehealth, under your brand or ours.

  • Telehealth platformsLongevity clinicsDiagnostics platformsPerformance medicineMen’s healthWomen’s health

The colour system

Every peptide gets a code and a colour. The hue marks its family, the shade marks the product. Built to scale from 8 launch SKUs to a 7,000-strong library.

View all products
  • 1XXCellular energy
  • 2XXSkin and hair
  • 3XXRecovery
  • 4XXGH and body composition
  • 5XXMetabolic
  • 6XXCognition and sleep
  • 7XXSexual health
  • 8XXImmune
WHY GEL

No more injecting. Just a gel under the tongue.

A simple daily dose that patients are happy to take, and that opens your peptide programme to everyone, including people who would never self-inject.

  • 01

    No needles

    A measured dose under the tongue. No syringes, no injection training, no sharps.

  • 02

    No reconstitution

    Ready to use. No bacteriostatic water, no dosing maths, no mixing errors.

  • 03

    Mucosal route

    Designed to sidestep gut degradation and first-pass metabolism.

  • 04

    Clean formulation

    GRAS-status ingredients in a no-heat process that protects the peptide.

THE DELIVERY PLATFORM

A gel matrix engineered for the oral mucosa.

The gel holds peptides against the mucosa under the tongue and inside the cheek, a route to the bloodstream designed to sidestep gut degradation and first-pass metabolism. GRAS-status ingredients, made in a no-heat process.

Early-stage data. Full summaries under NDA.
TISSUE MODEL / MATTEK2.4×Large-molecule permeation1,300 kDa hyaluronic acid versus untreated tissue. 2.1× versus HA alone.
LARGE MOLECULE~35kDaDetected in bloodHCG, far larger than most peptides, detected systemically 4 hours after application.
RANDOMISED · DOUBLE-BLINDRCTPlacebo-controlled trialNutrient formulation on the platform. Improved blood cell counts and sleep quality, no adverse effects reported.
HUMAN EVALUATION5 minTo blood presenceNutrient detected in blood within 5 minutes, effects sustained for 30 minutes. Peptide data under NDA.
TWO WAYS TO LAUNCH

Your brand, or our brand

01 · Private label

MOST PARTNERS

Your name, colours and packaging on our formulations. Patients only ever see you.

Packaging
YOUR BRAND
SKUs
ANY FROM THE RANGE
Minimum order
5,000 / SKU
First batch
[X] WEEKS
How private label works

02 · Geltides label

A finished, patient-ready brand for your platform. The fastest way to test demand before committing to your own label.

Packaging
GELTIDES OR CO-BRANDED
Minimum order
5,000 / SKU
Patient content
INCLUDED
Upgrade path
PRIVATE LABEL ANYTIME
See the range
  1. 01

    Choose your SKUs

    Pricing, study summaries and samples under NDA.

  2. 02

    Brand it

    We produce dispenser, carton and insert for your sign-off.

  3. 03

    Connect fulfilment

    Bulk office-use supply from the 503B, or patient-specific prescriptions dispensed by the 503A.

  4. 04

    Launch and reorder

    Batch release with a COA. Reorder on a set cycle.

WHY TRUST GELTIDES

Built for the diligence your clinical and legal teams will run.

Made in a state-licensed 503A pharmacy and an FDA-registered 503B outsourcing facility. The 503B operates under cGMP. Backed by a pharmaceutical supply group operating since 1999 [CONFIRM]. Every claim below comes with a document you can request.

  • ACTIVEState-licensed 503A pharmacyLicence [#######] · [N] states
  • ACTIVEFDA-registered 503BFEI [##########]
  • ACTIVE503B cGMP manufacturingLast inspection [DATE]
  • ACTIVEISO 17025 lab COAsLab: [LAB NAME]
  • PENDINGLegitScript certifiedID [#######]
  • PENDINGPatent pendingApplication [NUMBER]
  • ACTIVEProduct liabilityCover $[X]M
  • ACTIVEHIPAA BAAAvailable on request
  • PENDINGUK MHRA licenceExpected Q2 2027

Six gates before any supply commitment

NO SHORTCUTS ON MANUFACTURER, CUSTOMS, LICENSING OR SANCTIONS CONTROLS
  1. 01CounterpartyLegal entities, ownership and sanctions screening confirmed.
  2. 02ProductSKU identity, status and permitted route to market confirmed.
  3. 03QualitySamples matched to batch records and COA documentation.
  4. 04RouteStorage, shipping and chain-of-custody requirements validated.
  5. 05CommercialPricing, payment terms and contracting structure agreed.
  6. 06ContractSigned only after legal, tax and regulatory review.
SAFETY AND EVIDENCE
  • Independent tissue modelsPermeation and safety tested on reconstructed human tissue (MatTek).
  • No tissue damageNo structural damage or morphology changes across multiple compounds tested.
  • Randomised controlled designA randomised, double-blind, placebo-controlled study on the platform, with no adverse effects reported.
  • Clean human safety recordNo adverse effects reported in human studies to date. Observational peptide data is available to partners under NDA.
VERIFY EVERYTHING
Scan-to-COA on every labelEach batch code links to its certificate of analysis from an ISO 17025 lab.
Browse the public COA library [LINK]Request samples under NDA and MTA
SAMPLES GUARANTEE [CONFIRM TERMS]First samples at cost. Full refund if any batch fails specification.
Request samples
CASE STUDY · [PARTNER NAME]

"[Quote from partner on launching a needle-free peptide line with Geltides.]"

[Name], [Role], [Partner]
[X]%
PATIENT ADHERENCE VS INJECTABLES
[X] WKS
NDA TO FIRST PATIENT
[X]
PATIENTS IN PILOT
[X]%
REORDER RATE

The people behind Geltides

  • Patrick [Surname]CO-FOUNDER[Short bio: background, previous companies, why Geltides.]
    GELTIDES TEAM01
  • [Name], MDMEDICAL ADVISOR · [SPECIALTY]Board-certified in [specialty]. [Institution].
    MEDICAL ADVISORY BOARD02
  • [Name], PharmDPHARMACY ADVISOR · 503A / 503B[Years] in sterile and non-sterile compounding. [Institution].
    MEDICAL ADVISORY BOARD03
  • [Name], PhDSCIENTIFIC ADVISOR · PEPTIDES[Research focus]. [Institution].
    MEDICAL ADVISORY BOARD04

Talk to sales

Product sheet, wholesale pricing, study summaries and samples. Shared under mutual NDA. Reply within one business day.

partners@geltides.com